20-3740860-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000254963.7(HSPA12B):c.89C>T(p.Pro30Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,613,926 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000254963.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HSPA12B | NM_052970.5 | c.89C>T | p.Pro30Leu | missense_variant | 3/13 | ENST00000254963.7 | NP_443202.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HSPA12B | ENST00000254963.7 | c.89C>T | p.Pro30Leu | missense_variant | 3/13 | 1 | NM_052970.5 | ENSP00000254963 | P1 | |
HSPA12B | ENST00000399701.1 | c.-117-1424C>T | intron_variant | 1 | ENSP00000382608 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 250192Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135384
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461612Hom.: 1 Cov.: 31 AF XY: 0.0000248 AC XY: 18AN XY: 727126
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152314Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | The c.89C>T (p.P30L) alteration is located in exon 3 (coding exon 2) of the HSPA12B gene. This alteration results from a C to T substitution at nucleotide position 89, causing the proline (P) at amino acid position 30 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at